ELECSYS ACTH
Report
- Report Number
- 1823260-2023-03056
- Event Type
- Malfunction
- Date Received
- September 21, 2023
- Date of Event
- August 14, 2023
- Report Date
- October 16, 2025
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- CKG
- PMA / PMN Number
- K060585
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
BASED ON THE CURRENT INFORMATION, THE INVESTIGATION WAS UNABLE TO DETERMINE A SPECIFIC ROOT CAUSE. SAMPLE TYPE AND SAMPLE STABILITY ISSUES COULD NOT BE EXCLUDED. THE SAMPLES WERE REPEATEDLY FROZEN WHICH IS ALLOWED ONLY ONCE PER PRODUCT LABELING AND BEYOND THE STABILITY PER DOCUMENTED IN PRODUCT LABELING WHEN TESTED FOR THE PRELIMINARY INVESTIGATION. CALIBRATION AND QC DATA DO NOT SUGGEST ANY REAGENT ISSUE.
G1 CONTACT OFFICE-MANUFACTURING SITE WAS UPDATED.
THE SERIAL NUMBER OF THE COBAS 8000 CORE ANALYZER WAS REQUESTED BUT WAS NOT PROVIDED. THE INVESTIGATION IS ONGOING.
THERE WAS AN ALLEGATION OF QUESTIONABLE ACTH ELECSYS E2G RESULTS FROM THE COBAS 8000 CORE ANALYZER. THE RESULTS FROM THE CUSTOMER OVER TIME AFTER LOADING FOR ACTH: 0 MINUTES (SAMPLE 1): 100 PG/ML. 15 MINUTES (SAMPLE-2): 113 PG/ML. 30 MINUTES (SAMPLE-3): 110 PG/ML. ON 7-SEP-2023, THE PRELIMINARY INVESTIGATION TESTED THE SAMPLES ON A COBAS E801 MODULE: SAMPLE 1: 53.0 PG/ML. SAMPLE 2: 71.7 PG/ML. SAMPLE 3: 65.6 PG/ML. BASED ON THE RESULTS, THE CUSTOMER SUSPECTED A NON-SPECIFIC REACTION IN ROCHE ASSAY. NO INFORMATION WAS PROVIDED TO DETERMINE IF THE QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LAB.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1446817 | ELECSYS ACTH | ADRENOCORTICOTROPIC HORMONE (ACTH) TEST SYSTEM | CKG | ROCHE DIAGNOSTICS | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female |